Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects (≤ 45 Years) Hospitalized for an Ischaemic Stroke

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-01-11

Study Completion Date

2025-01-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Incidence of strokes has increased these last 20 years in young population. This rise could be linked to alcohol, tobacco or drug use like cannabis. Cannabis has previously been descripted as a potential factor of reversible vasoconstriction. The main objective is to show that an exhaustive assessment of a stroke facing a young person frequently lead to a diagnostic of reversible vasoconstriction due to cannabis use. Evaluation will focus on prevalence of strokes secondary to a reversible vasoconstriction attributable to cannabis in young subjects.

There's a real public healthcare interest in terms of primary and secondary prevention to evaluate the role of cannabis as a risk factor of stroke in young population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intracranial Arterial Stenosis and Resin of Cannabis Use

NCT02246140

Cannabis Users

RECRUITING NA

Neurocognitive Impairment After Ischemic Stroke

NCT06262529

Acute Ischemic Stroke

RECRUITING NA

Prediction of Patient-specific Outcomes After Interventional neuroRadiology Procedures

NCT04504695

Aneurysmal Disease Stroke

UNKNOWN

Addiction & Stroke

NCT06187025

Stroke

RECRUITING NA

Stroke Incidence and Risk Factors in a Tri-ethnic Region

NCT03266952

Diabetes Diet Epidemiology +2 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Cannabis Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Cannabis User

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cannabis User

Group Type OTHER

Drug urinal test

Intervention Type OTHER

Non Applicable

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Drug urinal test

Non Applicable

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Magnetic Resonance Imaging Computerized Tomography Scan Transcranial Doppler Ultrasound

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject between 18 and 45 years old
* Stroke confirmed by medical imaging
* Written informed consent (subject, nearby or emergency procedure)
* Subject affiliate to a local healthcare insurance office
* For female of childbearing potential, an adequate contraceptive measur

Exclusion Criteria

* Subject with psychiatric disorder, unable to understand the study or cooperate
* Subject under guardianship or forfeiture of liberty
* Pregnant or breastfeeding woman
* Subject in period of exclusion due to another study or still in follow-up of an interventional study

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No